E-ISSN 2146-3077
Original Article
Four Cutaneous Leishmaniosis Case Resistant to Meglumine Antimoniate Treatment
1 İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi, Tıbbi Mikrobiyoloji Anabilim Dalı, İstanbul, Türkiye  
2 İstanbul Üniversitesi, Cerrahpaşa Tıp Fakültesi, Dermatoloji Anabilim Dalı, İstanbul, Türkiye  
Turkiye Parazitol Derg 2014; 38: 177-180
DOI: 10.5152/tpd.2014.3410
This article was viewed 1709 times, downloaded 1769 times

Key Words: Lucilia sericata, larvae, cutaneous leishmaniasis, meglumine antimoniate resistant
Abstract

Objective: The aim of the study was to treatment of cutaneous leishmaniasis caused by meglumine antimoniate resistant Leishmania major with Lucilia sericata larvae.

 

Methods: Samples obtained from patients’ lesions were stained with Giemsa and examined under the microscope. The samples were also incubated to Novy-Nicolle-McNeal (NNN) and Roswell Park Memorial Institute (RPMI) 1640 media. ITS1 region real time PCR was performed for identfying the Leishmania species. The patients were treated using Glucantime® or liposomal amphotericin B or L. sericata larvae according to their response to the treatmet regimes.

 

Results: In the initial examination, amastigote forms of Leishmania were seen in the samples of all 4 patients under microscopic examination. Two of the patients with cutaneous leishmaniasis, which were caused by Glucantime resistant L. major were treated with liposomal amphotericin B, and two of them were treated with L. sericata larvae. Leishmania promastigotes were not grown in both cultures.

 

Conclusion: Cutaneous leishmaniasis, which wascaused by Glucantime resistant L. major has been successfully treated with L. sericata larvae in a very short time, 10 days. PCR results from samples taken 2 months after the treatment were examined and the results were negative. 

Key Words
Authors
All
Reviewer's Corner
Survey
AVES | Copyright © 2017 Turkish Parasitology Association | Latest Update: 06.07.2017